Hot Pursuit     06-Jul-23
CARE Ratings revises ST ratings of Panama Petrochem to 'A1+'
Panama Petrochem said that CARE Ratings has upgraded its rating on the short-term bank facilities of the company to 'CARE A1+' from 'CARE A1'.

The agency has reaffirmed its rating on the long-term bank facilities of Panama Petrochem at ‘CARE A+; Stable'.

CARE Ratings said that the re-affirmation of the long-term ratings and revision in short-term ratings assigned to the bank facilities of Panama Petrochem (PPL) factors in the consistent operating performance, strong capital structure and liquidity position with healthy debt protection metrics.

PPL's total operating income grew by around 5% in FY23 majorly due to improved sales realizations. The operating profitability margins have remained stable at 13.74% in FY23. This was on account of healthy capacity utilization of its manufacturing facilities with favourable changes in the product mix towards a higher share of value-added products and other cost-control measures implemented in the last few years.

The revision in short-term ratings considers improvement in the liquidity profile, backed by improvement in operating cycle, significant cash balance and low utilization of working capital limits. The company does not have any major capex plan in the medium term and the minor capex outlay in the range of Rs 20-25 crore each year is expected to be funded out of internal accruals.

The ratings continue to derive strength from experience of the promoters in the petrochemical industry with diverse product offerings and long-standing relationship with reputed clientele.

The ratings are, however, constrained by vulnerability of the company's profitability to the fluctuations in forex rates and base oil prices which are volatile being a crude oil derivative. The company's operations are also exposed to high competition in the industry from other established players.

Panama Petrochem is engaged in the business of manufacturing of petroleum derivative products which find application in industries such as cosmetics & pharmaceuticals, inks/coatings, textiles, automo bile, power, engineering, and rubber. The product portfolio includes liquid paraffin oils, petroleum jelly, ink oils, antistatic coning oil, rubber process oils, transformer oils, cable filling compounds and paraffin wax.

The company's consolidated net profit declined 9.61% to Rs 50.81 crore on a 0.43% rise in sales to Rs 510.40 crore in Q4 FY23 over Q4 FY22.

The scrip rose 0.46% to currently trade at Rs 306 on the BSE.

Previous News
  Panama Petrochem consolidated net profit rises 11.21% in the June 2022 quarter
 ( Results - Announcements 01-Aug-22   13:51 )
  Panama Petrochem to table results
 ( Corporate News - 13-May-24   12:09 )
  Panama Petrochem announces board meeting date
 ( Corporate News - 16-Jan-24   16:53 )
  Panama Petrochem to announce Quarterly Result
 ( Corporate News - 19-Jul-23   10:54 )
  Panama Petrochem consolidated net profit rises 1436.24% in the June 2021 quarter
 ( Results - Announcements 05-Aug-21   14:18 )
  Board of Panama Petrochem recommends final dividend
 ( Corporate News - 30-May-23   11:14 )
  Board of Panama Petrochem recommends interim dividend
 ( Corporate News - 09-Nov-23   12:16 )
  Panama Petrochem to declare Quarterly Result
 ( Corporate News - 28-Oct-17   10:40 )
  Panama Petrochem announces board meeting date
 ( Corporate News - 27-Jan-22   17:19 )
  Panama Petrochem consolidated net profit rises 310.39% in the December 2015 quarter
 ( Results - Announcements 11-Feb-16   14:31 )
  Panama Petrochem to convene board meeting
 ( Corporate News - 08-Jun-20   15:38 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top